The metalloproteinases ADAM10 and ADAM17 play a crucial role in cleaving Notch receptors, initiating downstream signaling that contributes to maintaining the invasive characteristics of tumors.532,533 Consequently, targeted inhibition of ADAM10 or ADAM17 represents a crucial approach to halting the progression of malignant tumors. Here, ADAM17 is linked to cancer.